本报告研究涉及企业/品牌/案例：济南馨福圆,爱博恩医学月子会所,喜喜母婴,新寰亚月子会所,馨月汇月子会所,悦悦满月子会所,超宝汇月子会所,人文国际月子会所,优宸国际月子中心,悠月母婴一站式月子会所,喜喜月子,知爱母婴CHERISH,贝瑞佳BABYSKY,悦子阁,悦笙YUESHENG,萌诺母婴养生,诗安国际月子会所,巍阁月子中心,禧月阁月子中心,宝月阁月子中心,圣贝拉母婴护理中心,杰玛家月子会所,禧月会月子中心,仕馨月子会所,悦宝荟月子会所,中端月子中心,莉泽产后护理中心,天玥府母婴护理中心,澳玥月子中心,禧月荟月子中心,爱帝宫,月来悦美月子中心,宝生月子中心,爱贝蕊恩韩式月子护理中心,壹心月子会所,谊远安丽,瑞和锦江,万达,建国,蓝海,开元,格兰云天,世纪金源,雷迪森,君澜,明宇等。

近年来，中国月子中心行业吸引不少资本投入，门店数量呈快速增长的态势。尤其在2016至2018年，在国家二孩政策的刺激下，中国所有大小规模的月子会所数量增长速度达50%-60%左右，预计2019年月子中心门店数量将突破4400个。
iiMedia Research（艾媒咨询）数据显示，自2013年的17.8亿元到2018年的142.2亿元，中国月子中心的市场规模年均复合增长率在50%左右。结合中国当前人口生育率情况来看，2021年后人口生育率可能有下降趋势，因此，月子中心的市场规模也会受到影响，但仍将保持近300亿元的市场规模。此外，艾媒咨询（iiMedia Research）调研显示，2019年，约有42.32%的消费者对国内的月子中心比较满意或非常满意。艾媒咨询分析师认为，目前月子中心正处于蓬勃发展阶段，预计未来一段时间仍保持增长趋势；但是由于行业水平参差不齐，并且还没有形成完备的市场监管标准，因此在2019-2020年月子服务行业会处于调整期，增速放缓。
According to iiMedia Research, from 1.78 billion yuan in 2013 to 14.22 billion yuan in 2018, the average annual compound growth rate of the market scale of China's monthly child center is about 50%. In view of China's current fertility rate, the population fertility rate may decline after 2021. Therefore, the market size of Yuezi Center will also be affected, but it will still maintain a market size of nearly 30 billion yuan. In addition, a survey by iiMedia Research shows that in 2019, about 42.32% of consumers are satisfied or very satisfied with the domestic month center. Ai Media Consulting analysts believe that the current month child center is in a booming stage and is expected to maintain a growth trend in the future; however, due to the uneven level of the industry and the lack of complete market regulatory standards, it is expected The confinement service industry will be in an adjustment period and the growth rate will slow down.
（以下为报告节选页，完整版共175页）

本报告研究涉及企业/品牌/案例：同仁堂，片仔癀，东阿阿胶，太极集团，胡庆余堂，同仁牛黄清心丸，黄芪颗粒，雷氏丹参片，云峰气血口服液，太极五子衍宗丸，太极生力雄丸，仲景左归丸，一笑堂龟甲壳，白云山复方丹参片，天士力养血清脑颗粒，白云山夏桑菊颗粒，白云山板蓝根颗粒

随着居民消费水平的提升和健康保健意识的增强，总体健康需求在扩大，进而推动中医药市场的发展，2018年中国中药材市场规模达1246亿元，同比增长22.40%，预计到2024年，中药材市场规模将达2004亿元。
iiMedia Research（艾媒咨询）调查显示，2019年接近五成受访者购买过中药材，滋补养生和治病是购买中药材的两大目的。由于中医药应用范围广泛，中医药产业链不断扩展延伸，并加速扩展和整合。同仁堂、片仔癀、东阿阿胶等中药巨头企业纷纷布局中药材后市场，建设中药大健康产业，如植物提取物、保健食品、中药化妆品等，已成为我国生命健康产业中最具成长性的组成部分。
According to the iiMedia Research survey, nearly 50% of respondents have bought Chinese herbal medicines in 2019, and tonic sage and cure are the two main purposes for buying Chinese herbal medicines. Due to the wide range of applications of Chinese medicine, the Chinese medicine industry chain continues to expand and expand and accelerate the expansion and integration. Tongrentang, tablets, Dong'a gum and other Chinese medicine giant enterprises have laid out the chinese medicine after the market, the construction of chinese medicine large health industry, such as plant extracts, health food, Chinese medicine cosmetics, etc., has become China's life and health industry in the most growth component.

（以下为节选页，完整版共88页）

本报告研究涉及企业/品牌/案例：白云山,同仁堂,云南白药,昆明制药,华润三九,天士力,央视财经,牛黄,薏仁,茯苓,黄芪,川芎,片仔癀,中国中药,紫鑫药业,九洲药业,陇神戎发,众生药业,通化金马,江中药业,寿仙谷,新天药业,盘龙药业,佛慈制药,昆药集团,香雪制药,六味地黄丸,人参养荣丸,四神丸,白蚀丸,血脂康胶囊,茵栀黄口服液,一捻金胶囊,乙肝益气解郁颗粒,二十七味定坤丸,十六味冬青丸,参芪消渴胶囊,十香返生丸,华润三九,红日药业,源和药业,太龙药业,中智药业，培力控股,盛实百草,芍花堂,亳药千草,汇群中药

国内经济增长以及居民消费水平的提高都刺激着中药医疗消费需求的增长。iiMedia Research（艾媒咨询）调查显示，有49%的受访用户倾向中医药治疗，与西药基本持平。2018年中国中药材市场规模达1246亿元，同比增长22.40%，在巨大的需求驱动下，中药材种植面积扩大，药材产量将会持续增长。

中药材主要包括上游种植、养殖市场，中游流通市场和下游销售市场三大环节。目前，中药饮片和中成药生产是中药产业的核心，主要包括中药加工，包括中药配方颗粒、中药饮片加工、中成药制造等。中药饮片领域方面，行业销售收入增速分别在2016和2018年触底回升，华润三九、中国中药、红日药业等上市公司表现良好；中药配方颗粒方面，2006-2016年，中国市场销售额占饮片市场销售额比重由1.2%增加至6.0%，中药配方颗粒或将成为中药饮片加工行业应用广泛的产品；中成药方面，随着国家医改政策的推行，中成药消费需求趋于合理，中成药产量开始回落，但仍处于一个比较高的产量水平，云南白药、白云山、同仁堂、紫鑫药业等上市企业表现良好。

Chinese medicinal materials mainly include upstream planting, breeding market, midstream circulation market and downstream sales market three links. At present, the production of Chinese medicine tablets and traditional Chinese medicine is the core of the Chinese medicine industry, including the processing of Traditional Chinese medicine, including Chinese medicine formula particles, Chinese medicine tablet processing, traditional Chinese medicine manufacturing. In the field of Chinese medicine tablets, the growth rate of sales revenue in the industry rebounded in 2016 and 2018, respectively, china Resources 39, Chinese medicine, Red Day Pharmaceuticals and other listed companies performed well; Chinese medicine formula particles may become a widely used product in the Chinese medicine tablet processing industry, Chinese medicine, with the implementation of the national medical reform policy, the consumption demand of traditional Chinese medicine tends to be reasonable, the production of Traditional Chinese medicine began to fall, but still at a relatively high level of production, Yunnan White Medicine, Baiyunshan, Tongrentang, Zixin Pharmaceutical and other listed enterprises performed well.

本报告研究涉及企业/品牌/案例：华西口腔医院,北京大学口腔医院,四川大学华西口腔医院,四川大学华西口腔医院,通策医疗,拜博口腔,瑞尔齿科,美维口腔,牙博士口腔,马泷齿科,佳美口腔,维尔口腔,美奥口腔,同步齿科,德伦口腔,爱牙,牙医管家,e看牙,牙e家,优益齿,共享牙医,牙医帮
截至2017年末，中国城市共有专业口腔医院535家，农村154家。艾媒咨询分析师认为，从专科医院领域的规模来看，在旺盛的医疗需求下，中国口腔市场还有很大的发展空间，特别是美颜经济兴起会进一步带动牙齿美白、矫正等业务发展。

从产业结构看，中国口腔行业主要包括牙种植、正畸、儿科、综合等项目，艾媒咨询分析师认为，目前中国口腔医疗正处于发展上升阶段，品牌开始获得一定认可，但发展主要集中在中低端市场，后续应当进一步向高端市场发力。从机构性质看，中国口腔医疗机构大致可分为综合性医院口腔科、公立专科口腔医院、连锁民营口腔医院及诊所和个体诊所四类。iiMedia Research（艾媒咨询）监测发现，首都医科大学附属口腔北京医院、泰康拜博等机构的排名靠前，受到更高认可度。

From the industrial structure, China's oral industry mainly includes dental implantation, orthodontics, pediatrics, comprehensive and other projects, Ai media consulting analysts believe that China's oral medicine is currently in the stage of development and rise, the brand began to get a certain recognition, but the development is mainly concentrated in the low-end market, the follow-up should further to the high-end market. From the institutional nature, China's oral medical institutions can be broadly divided into general hospital oral medicine, public specialized oral hospitals, chain private oral hospitals and clinics and individual clinics four categories. iiMedia Research monitoring found that the Capital Medical University affiliated oral Beijing Hospital, Taikang Baibo and other institutions ranked high, received a higher degree of recognition.

本报告研究涉及企业/品牌/案例：安健科技，万东医疗，康达国际，上海联影，深圳迈瑞佳能，飞利浦，柯达，西门子，GE，安健，万东，通用电气，安科，东软丹纳赫，罗氏，利德曼，强生，科华，美康，九强，日立，迈克，东芝，中生，雅培，迪瑞，大基康明，金杏，致远，成武，长庚，康健，鑫乐，瑞琦，力因精准，积水，威高，拱东，三力，阳普医疗，BD，奥凯龙，重庆多泰，成都威力生，广州暨华，威海威高，山外山，金宝，尼普洛，百特，贝朗，费森透析，美敦力，鱼疗，理邦，尚荣医疗，英科医疗

相比于全球医疗器械市场，近三年中国医疗器械市场的结构已趋向优化但结构依然严重不平衡。早期中国医疗器械市场中，中低端产品占据了将近70%的比例，而高端产品仅占30%左右的比例，而国际医疗器械市场的结构为高端产品占55%，低端产品占45%。如新华医疗、迪安诊断、乐普医疗、鱼跃医疗等积极开拓高端市场及寻求出海发展。艾媒咨询分析师认为，受人工智能、物联网、5G等技术的影响，高端化、智能化和家庭化是中国医疗器械产业发展最为显著的三大趋势。特别是医疗大数据、高端医疗影像设备、家用医疗器械、智能便携式医疗设备等领域将会备受关注。

Compared with the global medical device market, the structure of China's medical device market has been optimized in the past three years, but the structure is still seriously unbalanced. In the early Chinese medical device market, low-end products accounted for nearly 70% of the proportion, while high-end products accounted for only about 30%, while the international medical device market accounted for 55% of high-end products and 45% of low-end products. Such as Xinhua Medical, Dean Diagnostics, Lepu Medical, Yuyue Medical, etc. actively explore the high-end market and seek to develop. iiMedia Research analysts believe that high-end, intelligent and family-oriented are the three most significant trends in the development of China's medical device industry due to the impact of artificial intelligence, Internet of Things, 5G and other technologies. In particular, medical big data, high-end medical imaging equipment, home medical equipment, smart portable medical equipment and other fields will be of great concern.

本报告研究涉及企业/品牌/案例：松果倾诉

随着经济下行、社会关系变化、学业工作竞争加剧、婚恋等问题日益突出，现代人们生活面临的压力不断增加，来源更加多样化。艾媒商情舆情数据监测系统显示，网民对于生活负面情绪较大，网络口碑仅为32.2，且主题词云更多与精神压力、生活节奏、焦虑等词相关。面对生活中增多的烦恼压力，不同收入人群对其处理方式也不尽相同。iiMedia Research（艾媒咨询）数据显示，中等收入群体最愿意向他人倾诉烦恼，而经济收入越高，则越偏向于采取心理咨询的途径解决或减缓烦恼压力问题，20.2%的受访高收入网民遇到烦恼时愿意寻找心理咨询。在网民心理咨询需求提升的背景下，近年线上咨询平台得到快速发展，预计2019年中国精神类服务电商用户规模将超过4000万人。

With issues of the economic downturn, changes in social relations, intensified competition in academic and work, marriage disputes, etc. becoming increasingly prominent, modern people are facing increasing pressure in their lives and more diverse sources. As the iiMedia Big Data Public Opinion Monitoring System showed, the netizens have more negative emotions about life, with the Internet Reputation Index only reaching 32.2, and the keywords cloud is more related to mental stress, rhythm of life, anxiety, etc. Faced with the increasing stress in life, different income groups have different ways of dealing with it. As the data of iiMedia Research showed, middle-income groups are most willing to share their troubles with others. On the other hand, the higher the netizens’ income, the more inclined they are to adopt psychological counseling to solve or alleviate their troubles. 20.2% of the interviewed high-income netizens are willing to seek psychological counseling when they have troubles. In the context of increasing demand for online psychological counseling, online consulting platform has developed rapidly in recent years. It is expected that the scale of China Spiritual Service E-Commerce users will exceed 40 million in 2019.

本报告研究涉及企业/品牌/案例：飞顿医疗激光公司，奇致激光，Lumenis，CANDELA，华西生物，Allergan，昊海生物科技，中国生物兰州生物制品研究所有限责任公司，上海九院，北京八大处，四川华西，小红书，百度，微信，新氧，更美，悦美，美团，阿里健康

当前，中国轻医美市场供需迎来双增长，轻医美市场逐渐崛起。iiMedia Research(艾媒咨询)数据显示，预计2020年中国轻医美市场用户规模将达到1520万人。便捷、安全成轻医美消费重要推力，随着轻医美消费意识日益提升，轻医美或成中国消费者求美的“第一选择”。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展。医美机构加速拓展轻医美业务，轻医美诊所应运而生。与此同时，轻医美医生在流程操作、药械使用上更易实现规模化培养。在行业支持体系方面，互联网医美平台助推轻医美加速数字化升级，市场管理提效规范行业发展。在此背景下，中国轻医美消费市场迎来更好的发展空间。纵观当前中国轻医美消费新态势，供需协同并进以及行业支持体系日益完善，轻医美消费已逐渐成为求美新主流。

At present, the supply and demand of China's light medical beauty market is experiencing double growth, and the light medical beauty market is gradually rising. According to iiMedia Research, it is estimated that the user scale of China's light medical beauty market will reach 15.2 million in 2020. Convenience and safety have become an important driving force for the consumption of light medical beauty. With the increasing consumer awareness of light medical beauty, light medical beauty or become the “first choice“ for Chinese consumers seeking beauty. Driven by the awakening of consumer consciousness and consumer demand, institutions and doctors have strongly boosted the rapid development of the light medical beauty industry on the supply side. Medical beauty institutions to accelerate the expansion of light medical beauty business, light medical beauty clinic came into being. At the same time, it is easier for doctors to realize large-scale cultivation in process operation and medical device use. In terms of the industry support system, the Internet medical beauty platform promotes the digitalization and upgrading of medical beauty, and market management improves the efficiency and standardizes the development of the industry. In this context, China's light medical beauty consumer market usher in a better space for development. In view of the new trend of China's light medical beauty consumption, the coordinated development of supply and demand and the increasingly perfect industry support system, light medical beauty consumption has gradually become the new mainstream of seeking beauty.

本报告研究涉及企业/品牌/案例：宝宝树，亲宝宝，柚宝宝，妈妈网，宝宝知道，妈妈帮，育儿网，辣妈帮，蜜芽

随着二胎政策全面推广以及移动互联网的普及，中国移动母婴行业走上稳健发展的步伐，2019年用户规模将达到2.04亿人。而目前90及95后人群开始走进适育年龄，移动母婴平台的用户开始更替，这部分人群在较为宽松及呵护的环境下成长，对互联网依赖程度高，因此更为青睐使用能提供更多元服务的产品。iiMedia Research（艾媒咨询）数据显示，受访母婴用户用户在平台上最偏好获取育儿知识相关资讯，占比达52.1%。而偏好获取备孕知识、生理健康、孕期护理相关资讯的用户占比也均超过三成，用户资讯获取需求呈现多元化特点。针对用户需求的变化，能综合资讯、知识、交流、电商的综合母婴平台目前成为移动母婴行业的主流。

With the overall promotion of the second child policy and the popularity of the mobile Internet, China Mobile Maternal and Infant Industry has stepped onto a steady pace of development, and the scale of users will reach 204 million in 2019. At present, post-90s and post-95s begin to enter the age of fertility, and the users of mobile maternal and infant platforms begin to change. This group of the population grows up in a more relaxed and caring environment, and is highly dependent on the Internet. Therefore, they prefer to use products that can provide more diversified services. As the data of iiMedia Research showed, interviewed users of mobile maternal and infant platforms preferred to obtain information related to parenting knowledge on the platform, accounting for 52.1%. Meanwhile, more than 30% of the users prefer to acquire information related to pregnant knowledge, physical health and pregnancy care, and their needs for information acquisition are diversified. In response to the changing needs of users, the integrated maternal and infant platforms that integrates information, knowledge, communication and e-commerce services has become the mainstream of the mobile maternal and infant industry.

本报告研究涉及企业/品牌/案例：霸王，章光101，得生源，the body shop,三生制药集团，曼迪旗舰店，索芙特，雍禾植发，南方医院，伊美尔，美莱，恒博，银河整形，今日头条，新氧，更美，悦美，小红书，豆瓣，Restoration Robotics，碧莲盛植发，Balmain，HairUWear集团，ARTMICRON,SOCAP,瑞贝卡，海森林，艾瑞美，佰丝堂，带没死，SIV西芙，阿芙洛蒂，宫秀假发

iiMedia Research（艾媒咨询）数据显示，2019年中国约有2.5亿脱发人群，女性群体接近1亿人，并且脱发群体的年轻化趋势明显，有60%的人在25岁就出现脱发现象。脱发群体的共同需求催生了毛发保健产业，涵盖洗护、保健品、理疗、医美、电商等多元业态，特别推动了养发护理（如霸王、章光101）、植发机构（如碧莲盛、雍禾植发）、假发产业（如瑞贝卡）等的蓬勃发展。艾媒咨询分析师认为，技术的成熟、社会的互联网化等因素将推动脱发催生产业进入新的发展阶段，未来3D技术，人工智能、医疗技术等的发展将进一步推动植发产业及电子生发产业升级。

According to iiMedia Research, there are about 250 million people with hair loss in China in 2019, with a female population of close to 100 million, and the trend towards youth in the hair loss group is clear, with 60 percent of people developing hair loss at the age of 25. The common needs of hair loss groups have spawned the hair care industry, covering a variety of industries such as shampoo, health care products, physiotherapy, medical beauty, e-commerce, etc., and in particular promoted the vigorous development of hair care (such as overlord, Zhang Guang 101), hair care institutions (such as bililian, hair, hair), wig industry (such as Rebecca) and so on. Ai media consulting analysts believe that the maturity of technology, social Internet and other factors will promote hair loss industry into a new stage of development, the future of 3D technology, artificial intelligence, medical technology and other development will further promote the development of hair-growing industries and electronic hair industry.

本报告研究涉及企业/品牌/案例：恒瑞医药，白云山，111集团，平安好医生，好大夫在线，优健康，春雨医生，微医，丁香医生，和美医疗，北大医疗，PHG,新氧，联合丽格，正广兴家庭医生，强森医疗，微脉，美中嘉和，零氪科技，中有精准医疗，思派网络，普瑞眼科，臻和科技，移宇科技，小鹿医馆，妈咪知道，八百方，京东医药，阿里健康大药房，1药网，一心堂，健一网，好药师，健客网，美丽神器，更美，悦美，美莱整形，伊美尔，丽都整形，芝星整形，欧华美科

大健康产业细分领域的垂直深化，推动了大健康产业格局的不断完善。受政策鼓励和资本推动的影响，2019年，大健康产业在患者服务类领域、医疗服务类领域、医药服务类领域、医疗美容类领域和医疗保健类领域等细分场景快速发展。以恒瑞医药、白云山为代表的传统医药上市公司和以平安好医生、111集团和新氧科技为代表的互联网医疗上市企业各自占据大健康产业领域的一席之地。艾媒商情舆情监测系统数据显示，受2018年和2019年上半年医疗领域负面舆情的影响，大健康产业各上市企业正从低谷平稳回升。艾媒咨询分析师认为，受社会医疗需求和国家政策的推动，大健康产业仍是未来投资的亮点。

The vertical deepening of the large health industry segment has promoted the continuous improvement of the pattern of the big health industry. Influenced by policy encouragement and capital promotion, in 2019, the big health industry developed rapidly in the sub-sectors such as patient service, medical services, medical services, medical and beauty, and health care. The traditional pharmaceutical listed companies represented by Hengrui Medicine and Baiyun Mountain and the Internet medical listed companies represented by Ping An Doctor, 111 Group and New Oxygen Technology each occupy a place in the field of large health industry. According to data from the Aibu Business Intelligence Monitoring System, the listed companies in the big health industry are recovering steadily from the bottom of the market due to the negative public sentiment in the medical field in the first half of 2018 and 2019. Ai Media Consulting analysts believe that the health industry is still the highlight of future investment, driven by social medical needs and national policies.